Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oropharyngeal Neoplasms × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Radiotherapy, Intensity-Modulated 10 Cisplatin 9 Cetuximab 4 Carboplatin 4 Radiotherapy 3 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Restraint, Physical 2 Radiation 2 Nivolumab 2 Cyclophosphamide 2 Bupropion 2 Acupuncture Therapy 2 utomilumab 1 pembrolizumab 1 ficlatuzumab 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Sugars 1 Standard of Care 1 Psychiatric Rehabilitation 1 Pregabalin 1 Polymerase Chain Reaction 1 Platinum 1 Pilocarpine 1 Palliative Care 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡